CancerConsultants Announces Recent Updates to the Multiple Myeloma Information Center

As of April 25, 2008 has completed our most recent updates to our Multiple Myeloma Information Center, adding the latest findings in treatment and cancer management to our comprehensive, in-depth multiple myeloma content.

As part of Cancer Consultants’ ongoing mission to provide interested individuals, cancer patients, and their families and caregivers with access to the most current information about the prevention, screening, treatment, and overall management of cancer, we regularly update our content with recent, ground-breaking findings in all aspects of cancer prevention and care. Our almost thirty unique Cancer Information Centers cover a broad range of cancer types and subtypes, each providing readers with up-to-date disease overviews as well as the latest information on screening, prevention, and treatment. Each information center also features links to late-breaking news, tips for patients, newsletter subscriptions, clinical trials information, online communities, and more.

Featured Multiple Myeloma Information Center Update:

Updates to the Multiple Myeloma Information Center discuss the importance of three newer drugs for multiple myeloma: Thalomid® (thalidomide), Revlimid® (lenalidomide), and Velcade® (bortezomib); the role of autologous and allogeneic stem cell transplants; supportive care issues such as the management of bone complications; and strategies to further improve treatment outcomes.

For more of the latest information on multiple myeloma, visit the Multiple Myeloma Information Center.